Enanta Pharmaceuticals (ENTA) EPS (Diluted) (QoQ) (2012 - 2026)
Enanta Pharmaceuticals (ENTA) EPS (Diluted) (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Enanta Pharmaceuticals | 376.07 Mn | 212.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.56% |
| Dec 31, 2025 | 99.95% |
| Sep 30, 2025 | -102,534.54% |
| Jun 30, 2025 | 19.47% |
| Mar 31, 2025 | -1.03% |
| Dec 31, 2024 | 99.92% |
| Sep 30, 2024 | -127,247.22% |
| Jun 30, 2024 | 27.32% |
| Mar 31, 2024 | 7.08% |
| Dec 31, 2023 | 99.87% |
| Sep 30, 2023 | -65,658.89% |
| Jun 30, 2023 | -3.64% |
| Mar 31, 2023 | -28.57% |
| Dec 31, 2022 | 99.89% |
| Sep 30, 2022 | -83,448.38% |
| Jun 30, 2022 | 6.36% |
| Mar 31, 2022 | -10.66% |
| Dec 31, 2021 | 99.96% |
| Sep 30, 2021 | -341,328.63% |
| Jun 30, 2021 | 33.85% |